Hisamitsu Pharmaceutical Co., Ltd, a subsidiary of Hisamitsu Pharmaceutical Co., Inc., is a Taiwanese company located in Taipei. The firm manufactures and markets pharmaceuticals.

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Eastman Chemical Co. engages in the provision of specialty chemicals. It operates through the following segments: Advanced Material (AM), Additives and Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets its polymers, films, and plastics with differentiated performance properties for value-added end uses in transportation, consumables, building and construction, durable goods, and health and wellness markets. The AFP segment includes chemicals for products in the transportation, consumables, building and construction, animal nutrition, crop protection, energy, personal and home care, and other markets. The CI segment consists of large scale and vertical integration from the cellulose and acetyl, olefins, and alkylamines streams to support operating segments with advantaged cost positions. The Fibers segment offers cellulose acetate tow for use in filtration media, primarily cigarette filters. The company was founded by George Eastman in 1920 and is headquartered in Kingsport, TN.

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Mepha is a Swiss-based innovative pharmaceutical company developing, manufacturing and marketing branded and non-branded generic products in more than 50 countries. Mepha manufactures many of its products in Aesch/Basel -- Switzerland, to a high Swiss-quality standard. Mepha’s R & D organization has developed improved branded generics either through new formulations or using drug delivery technologies, providing additional benefits for healthcare professionals and patients. Furthermore, Mepha is actively involved in researching malaria treatments for adults and children.

Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.\nThe units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.

MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI.

Hankook Korus Pharm Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include antibiotics, health suppliments, antivirus, and others. The company was founded on February 12, 1999 and is headquartered in Chuncheon, South Korea.

Part of SourceBio International Plc, Quinoderm Ltd is a company headquartered in Hollinwood, UK, that manufactures and sells acne products and pharmaceuticals. On January 02, 2001 Source BioScience Ltd. acquired Quinoderm Ltd for $5.59 million.

Guangzhou Shipu Electronics Co., Ltd., established on 2006-04-17, Business scope includes production of new technology non-ferrous metal materials:compound semiconductor material(gallium arsenide,gallium phosphide,Indium phosphide,GaN),High temperature superconducting materials,memory alloy material(Titanium Nickel,Copper-based and iron-based memory alloy materials),super fine(Nano)Calcium carbide and superfine(Nano)Crystalline Carbide,superhard composite material,Precious Metal Composite,Light metal composite materials and combination of dissimilar materials,Aluminum foil for heat sink,Medium and high voltage cathode capacitor aluminum foil,Special large aluminum alloy profile,Aluminum alloy precision die forgings,Electrified Railway Overhead Conductors,Ultra-thin copper strip,Corrosion-resistant heat exchanger copper alloy,High Performance Copper Nickel,Copper-iron alloy strip,Beryllium Copper Strip,Wire,Tube and rod processed material,High temperature and anti-aging tungsten wire,Magnesium alloy casting,lead-free solder,Magnesium alloy and its application products,aluminum foam,Titanium alloy smelting and processing,Atomic grade zirconium sponge,Tungsten and molybdenum deep processing products;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Import and export(Except for commodities involving special management regulations on foreign investment access and licensing approval);Technology Import and Export;New material technology promotion service;New material technology development service;New material technical consultation,communication service;New material technology transfer service;Environmental protection technology promotion service;Environmental Technology Development Services;Environmental Technology Consulting,communication service;Environmental technology transfer service;Wholesale of electronic components;Wholesale of electronic products;Development and manufacture of special electronic materials(Except development and manufacture of optical fiber preform);

Chongqing Huapont Pharmaceutical Co. Ltd., part of Huapont Life Sciences Co., Ltd., is a company headquartered in Chongqing, China. The firm manufactures pharmaceutical products.

Medrx Co. Ltd. engages in the business of pharmaceutical drug development based on the transdermal absorption. It develops new value-added medicines by the drug formulation technology based on ILTS (Ionic Liquid Transdermal System), a unique technologies using ionic liquid and unique transdermal drug delivery technology using nano-sized colloid transdermal system for drugs. The company was founded by Masayoshi Matsumura on January 15, 2002 and is headquartered in Higashikagawa, Japan.

Part of Panfin Srl, Foodinvest Group SRL is an Italian company located in Teramo that manufactures food products.

Shenyang Aluminum-Magnesium Design and Research Institute Co., Ltd., established on 1991-01-17, The scope of business includes labor personnel required for foreign dispatch projects;type,copy;Mining and dressing of non-ferrous metal and non-metal mines;Light metal smelting;Nonferrous metallurgy,construction work,metallurgy,Municipal public,chemical industry,electricity,Building materials engineering survey and design,consult,supervision,Engineering contracting and equipment,sales of materials;Environmental Assessment;automatic fire alarm,Automatic fire extinguishing engineering design;Computer hardware and software and complete sets of equipment,Non-standard equipment,Environmental friendly,Power supply and distribution,Industrial automation system and building intelligent system technology development and sales,technical consulting,Serve,Technology transfer and commissioning;Survey of foreign and domestic-funded projects,consult,Design and Supervise Projects;Contract overseas projects and domestic international bidding projects and export of required equipment and materials;Realtor;binding,Post pictures;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);design,make,release,Acting for various domestic and foreign advertisements.<light metal>magazine publishing,issued;Conference Services..(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

LG H&H Co., Ltd. engages in the production and sale of household goods and cosmetic products. It operates through following divisions Beauty, Health and Refreshment businesses. The Beauty business division provides anti-aging cosmetic products. The Health division markets healthcare, skincare and household products. The Refreshment division provides soda, juice, energy drinks and other beverages. The company was founded on April 3, 2001 and is headquartered in Seoul, South Korea.